RU2019116422A3 - - Google Patents

Download PDF

Info

Publication number
RU2019116422A3
RU2019116422A3 RU2019116422A RU2019116422A RU2019116422A3 RU 2019116422 A3 RU2019116422 A3 RU 2019116422A3 RU 2019116422 A RU2019116422 A RU 2019116422A RU 2019116422 A RU2019116422 A RU 2019116422A RU 2019116422 A3 RU2019116422 A3 RU 2019116422A3
Authority
RU
Russia
Application number
RU2019116422A
Other languages
Russian (ru)
Other versions
RU2019116422A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019116422A publication Critical patent/RU2019116422A/ru
Publication of RU2019116422A3 publication Critical patent/RU2019116422A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2019116422A 2016-11-11 2017-11-09 Фармацевтическое применение композиции пролонгированного действия, содержащей пирфенидон, для лечения и обращения течения стеатогепатита человека (nafld/nash) RU2019116422A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MX2016014775A MX364040B (es) 2016-11-11 2016-11-11 Uso farmacéutico de una composición que contiene pirfenidona de liberación prolongada (pfd-lp) para la reversión y tratamiento de la esteatohepatitis humana (nafld/nash).
MXMX/A/2016/014775 2016-11-11
PCT/MX2017/000129 WO2018088886A1 (es) 2016-11-11 2017-11-09 Uso farmacéutico de una composición que contiene pirfenidona de liberación prolongada (pfd-lp) para la reversión y tratamiento de la esteatohepatitis humana (nafld/nash)

Publications (2)

Publication Number Publication Date
RU2019116422A RU2019116422A (ru) 2020-12-11
RU2019116422A3 true RU2019116422A3 (cg-RX-API-DMAC7.html) 2021-04-09

Family

ID=61193005

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019116422A RU2019116422A (ru) 2016-11-11 2017-11-09 Фармацевтическое применение композиции пролонгированного действия, содержащей пирфенидон, для лечения и обращения течения стеатогепатита человека (nafld/nash)

Country Status (21)

Country Link
US (3) US20190262325A1 (cg-RX-API-DMAC7.html)
EP (1) EP3539537B1 (cg-RX-API-DMAC7.html)
JP (2) JP2019535822A (cg-RX-API-DMAC7.html)
KR (2) KR20240065330A (cg-RX-API-DMAC7.html)
CN (2) CN115969802A (cg-RX-API-DMAC7.html)
AR (1) AR110057A1 (cg-RX-API-DMAC7.html)
AU (3) AU2017358367B2 (cg-RX-API-DMAC7.html)
CA (1) CA3043300A1 (cg-RX-API-DMAC7.html)
CL (1) CL2019001280A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019004799A2 (cg-RX-API-DMAC7.html)
EC (1) ECSP19031851A (cg-RX-API-DMAC7.html)
IL (1) IL266519A (cg-RX-API-DMAC7.html)
JO (1) JOP20190102A1 (cg-RX-API-DMAC7.html)
MA (1) MA45754A1 (cg-RX-API-DMAC7.html)
MX (1) MX364040B (cg-RX-API-DMAC7.html)
PE (1) PE20191149A1 (cg-RX-API-DMAC7.html)
PH (1) PH12019501047A1 (cg-RX-API-DMAC7.html)
RU (1) RU2019116422A (cg-RX-API-DMAC7.html)
UY (1) UY37478A (cg-RX-API-DMAC7.html)
WO (1) WO2018088886A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201903012B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.
JP2021504479A (ja) * 2017-11-28 2021-02-15 アイガー・バイオファーマシューティカルズ・インコーポレイテッドEiger Biopharmaceuticals, Inc. 非アルコール性脂肪性肝炎の処置のための方法および医薬組成物
MX368750B (es) 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
WO2020115774A1 (en) 2018-12-06 2020-06-11 Cipla Limited High drug load extended release formulations
AU2021365528A1 (en) * 2020-10-23 2023-06-15 Hq Han Bifunctional antagonists of tumor necrosis factor-alpha and transforming growth factor-beta and uses thereof
CN116159056A (zh) * 2023-03-09 2023-05-26 中南大学湘雅医院 一种氟非尼酮在制备非酒精性脂肪性肝炎药物中的应用
CN117007806A (zh) * 2023-09-21 2023-11-07 中国人民解放军军事科学院军事医学研究院 靶向肝巨噬细胞内lxr用于控制慢乙肝进展

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234812D1 (de) * 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
WO2005000227A2 (en) * 2003-06-06 2005-01-06 Intermune, Inc. Methods of treating tnf-mediated disorders
CN100542532C (zh) * 2004-05-24 2009-09-23 上海睿星基因技术有限公司 吡非尼酮在制备治疗肝损伤坏死和急性肺损伤的药物中的用途
US20110288134A1 (en) * 2008-10-29 2011-11-24 Pacific Therapeutics Ltd. Composition and method for treating fibrosis
US7635707B1 (en) * 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
CN101972236A (zh) * 2010-10-13 2011-02-16 北京诚创康韵医药科技有限公司 一种含吡非尼酮的缓释制剂
MX2011007675A (es) * 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
CN102488660A (zh) * 2011-12-15 2012-06-13 西安天一秦昆制药有限责任公司 一种含吡非尼酮的缓释微丸
CN103550242B (zh) * 2013-11-22 2015-07-15 四川国康药业有限公司 一种治疗肝纤维化的药物组合物及其制备方法

Also Published As

Publication number Publication date
US20190262325A1 (en) 2019-08-29
KR20190084056A (ko) 2019-07-15
MX364040B (es) 2019-04-11
IL266519A (en) 2019-07-31
JP2019535822A (ja) 2019-12-12
US20250325530A1 (en) 2025-10-23
PE20191149A1 (es) 2019-09-02
AU2024200737A1 (en) 2024-02-22
JP2022173344A (ja) 2022-11-18
CN115969802A (zh) 2023-04-18
EP3539537B1 (en) 2026-07-15
EP3539537A1 (en) 2019-09-18
CO2019004799A2 (es) 2019-07-31
CA3043300A1 (en) 2018-05-17
RU2019116422A (ru) 2020-12-11
AR110057A1 (es) 2019-02-20
MA45754A1 (fr) 2019-12-31
AU2017358367B2 (en) 2023-11-09
CN110248646A (zh) 2019-09-17
MX2016014775A (es) 2018-05-10
US20230181550A1 (en) 2023-06-15
CL2019001280A1 (es) 2019-07-19
ECSP19031851A (es) 2019-06-30
WO2018088886A1 (es) 2018-05-17
AU2017358367A1 (en) 2019-05-30
PH12019501047A1 (en) 2019-12-11
ZA201903012B (en) 2020-09-30
KR20240065330A (ko) 2024-05-14
UY37478A (es) 2018-05-31
AU2026200298A1 (en) 2026-02-05
JOP20190102A1 (ar) 2019-05-06

Similar Documents

Publication Publication Date Title
BR112019002665A2 (cg-RX-API-DMAC7.html)
BR112018004986A2 (cg-RX-API-DMAC7.html)
BR112019008105A2 (cg-RX-API-DMAC7.html)
BR112019001429A2 (cg-RX-API-DMAC7.html)
BR212018070320U2 (cg-RX-API-DMAC7.html)
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112019000061B1 (pt) Comutação e modulação de splicing de pré-mrna compreendendo porções de arcabouço bicíclico, com características melhoradas para o tratamento de distúrbios genéticos
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112019006736A2 (cg-RX-API-DMAC7.html)
CN303635691S (zh) 多功能暗装入墙盒
CN303653389S (zh) 包装盒(儿童馄饨)
CN303640822S (zh) 触控笔
CN303605504S (zh) 用于通讯装置的图形用户界面
CN303538091S (zh) 柱式床(mk10)
CN303537476S (zh) 飞碟吊椅
CN303569693S (zh) 边几(110479 Spencer)
CN303538222S (zh) 护颈枕(2)
CN303564565S (zh) 光站模块
CN303536045S (zh) 嫁衣(15)
CN303537535S (zh) 车家床(四六分圆拉床半围)
CN303536110S (zh) 眼罩(花纹)
CN303536111S (zh) 眼罩(条纹)